How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators. (Q45927317)

17 December 2017

title

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators. (English)

1 reference

17 December 2017

author

Ronan Conroy

5

1 reference

17 December 2017

Peter H. Whincup

12

1 reference

17 December 2017

Guy De Backer

8

object named as

Guy De Backer

1 reference

17 December 2017

Marie Therese Cooney

1

0 references

Pekka Jousilahti

9

object named as

Pekka Jousilahti

1 reference

17 December 2017

Alessandro Menotti

7

object named as

Alessandro Menotti

1 reference

17 December 2017

author name string

Alexandra Dudina

2

1 reference

17 December 2017

Dirk De Bacquer

3

1 reference

17 December 2017

Anthony Fitzgerald

4

1 reference

17 December 2017

Susana Sans

6

1 reference

17 December 2017

Ulrich Keil

10

1 reference

17 December 2017

Troels Thomsen

11

1 reference

17 December 2017

Ian Graham

13

1 reference

17 December 2017

SCORE Investigators

14

1 reference

17 December 2017

publication date

1 June 2009

1 reference

17 December 2017

European Journal of Cardiovascular Prevention and Rehabilitation

published in

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

304-314

1 reference

17 December 2017

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

HDL cholesterol and 24-year mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Regulation of reverse cholesterol transport and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

New cardiovascular risk factors exist, but are they clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

New cardiovascular risk determinants do exist and are clinically useful

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

Rationale, design, methods and baseline characteristics of the Asklepios Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213140

10.1097/HJR.0B013E3283213140

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017